Tag Archive | "controversy"

FDA, Aduhelm

Aduhelm, New Alzheimer’s Drug, Tangled in Controversy

Biogen estimates a target population of between 1 million to 1.2 million individuals could use this new drug. One Wall Street firm estimates that Biogen could reach Aduhelm sales of $5 billion by 2025.

Read the full story

Posted in Health, PushbackComments (0)

Join Now for the 50 Plus Newsletter